Einstein-Mount Sinai Diabetes Research Center

Biomedical Cores

New Core Developments

Coming soon: 1) Electromyography for the determination of muscle contraction; 2) Sciex 6500+ QTRAP with Selexion ion mobility for targeted metabolites, CyTOF, multiplexed immunohistochemistry and; 3) biophotonic in vivo imaging and Syntac immuno-technologies.

 

Animal Physiology Core
The Einstein-Sinai Diabetes Research Center Animal Physiology Core assists biomedical investigators in the in vivo assessment of glucose and fatty acid metabolism, insulin sensitivity and energy homeostasis in mice and rats.

Biomarker and Analytical Research Core (BARC)
Effective April 1, 2020, core services will be discontinued via the ES-DRC. Services will continue via the institution. 

The Einstein-Sinai Diabetes Research Center Biomarker and Analytical Research Core provides cutting-edge technology for the development and quantitative measurement of analytes and hormone biomarkers applicable to human and animal diabetes, obesity and metabolism based research efforts spanning the T1-T3 spectrum.

The Human Islet & Adenovirus Core (HIAC)
The Einstein-Sinai Diabetes Research Center Human Islet & Adenovirus Core provides key methodologies, technology and infrastructure to support investigators in the use of human islets for research studies.

Stable Isotope & Metabolomics Core
The Einstein-Sinai Diabetes Research Center Stable Isotope & Metabolomics Core uses stable isotope flux and metabolite profiling to help formulate and test hypotheses about the metabolic consequences of various changes in gene expression and protein function, in order to guide further integrative systems biology analyses of the underlying mechanisms in diabetes, insulin resistance, obesity, and diabetic complications.

Translational Research Core
The Einstein-Sinai Diabetes Research Center Translational Research Core delivers consultation, technical support, and training and mentoring in clinical research methods that are specifically applicable to diabetes, its complications, and related metabolic defects.

Immuno-Technology Core (NEW)
The Einstein-Sinai Diabetes Research Center Immuno-Technology Core has been conceived as an education, coordination and service core that will provide a paradigm for inter-institutional cooperation and will be the focus of directed recruitment and expansion of our diabetes immunology research base.